Pharma Promotion / Litigation
Litigation (10 jurisdictions)
134 records since 1990, judged by Jev for relevance, jurisdiction, type and importance.
2026 31
- KoreaLitigation2026-09-28hitnews.co.krJW Pharma Wins KFTC ‘Academic Marketing’ Case
- United StatesLitigation2026-09-26Lawsuit Information CenterGabapentin Dementia Lawsuit
- ChinaLitigation2026-09-22光明网Accepted 46 bribes in 11 years, with a total amount of 184 million yuan involved. A hospital in Hebei has been "hunted" by more than 30 pharmaceutical companies for a long time11年受贿46次 涉案金额累计1.84亿元 河北一医院被30多家药企长期“围猎”
- United StatesLitigation2026-09-21Latham & Watkins LLPDompe Settlement Highlights DOJ Continued Scrutiny of Pharmaceutical Manufacturer Donations
- KoreaLitigation2026-09-21news.sbs.co.krShock Lawsuit Over Vision Loss After Taking Wegovy... "Foreign Countries Already Issued Warnings," What About Korea?
- KoreaLitigation2026-09-18여성소비자신문Kwangdong Pharmaceutical and GC Cell initiate legal action for illegal comparative advertising... Obtained approval for use for therapeutic purposes at GCC 2005광동제약·지씨셀, 불법 비교광고 행위 법적 조치 착수...GCC2005 치료목적 사용승인 획득
- ChinaLitigation2026-09-13珠海网The National Medical Insurance Administration announced a commercial bribery case involving medical institutions in the purchase and sale of medicines国家医保局公布医疗机构涉医药购销商业贿赂案
- United StatesLitigation2026-09-11RegtechtimesDompé u.s. agrees to pay $32m to resolve false claims act liability relating to self-disclosure of patient kickbacks — DOJ
- United StatesLitigation2026-09-10Washington TimesDompe to pay $32 million over Medicare co-pay scheme for eye drug
- AustraliaLitigation2026-09-02AFRNovartis lawsuit accuses Australian boss of double-dealing with Bastas
- United StatesLitigation2026-08-26JDSupraCooperation, Compliance, and Consequences: Inside DOJ's $46 Million Veloxis Settlement
- RussiaLitigation2026-08-12БанкфаксAltai antimonopoly officials opened a case for violating the ban on advertising prescription drugsАлтайские антимонопольщики возбудили дело о нарушении запрета на рекламу рецептурных лекарств
- United StatesLitigation2026-08-11Washington TimesDrugmaker admits paying kickbacks to boost transplant drug prescriptions
- United StatesLitigation2026-08-10U.S. Department of JusticeVeloxis Pharmaceuticals Agrees to Pay $46 Million to Resolve Criminal and Civil Liability for Kickback Scheme
- United StatesLitigation2026-08-10U.S. Department of JusticeVeloxis Pharmaceuticals Agrees to Pay Over $46M to Resolve Criminal and Civil Liability for Kickback Schemes
- United KingdomLitigation2026-08-07Chemist+DruggistWeight loss POMs remain at centre of MHRA ad investigations
- United StatesLitigation2026-08-03Pharmaceutical ExecutiveSandoz Agrees to $450 Million Settlement With 43 US States Over Generic Drug Antitrust Claims
- United StatesLitigation2026-07-24Fierce PharmaNovo escalates Lilly false advertising suit with planned bid to halt comparative ads
- United StatesLitigation2026-07-22NBC 4 New YorkNovo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising
- United StatesLitigation2026-07-22Medical DialoguesNovo Nordisk Files False Advertising Lawsuit Against Eli Lilly Over Zepbound Ads
- United StatesLitigation2026-07-22ChosunbizNovo Nordisk sues Eli Lilly over Mounjaro–Wegovy ad claims - CHOSUNBIZ
- United StatesLitigation2026-07-21Pharmaceutical CommerceWhy Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads
- United StatesLitigation2026-07-21The HillNovo Nordisk sues rival Eli Lilly over weight loss drug advertising
- United StatesLitigation2026-07-21Yahoo FinanceNovo Nordisk sues Eli Lilly over GLP-1 drug advertising claims
- United StatesLitigation2026-07-21Barron'sNovo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising
- United StatesLitigation2026-07-21International Business TimesNovo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It’s Suing
- United StatesLitigation2026-07-21outlookbusiness.comNovo Nordisk Sues Eli Lilly; Alleges Misleading Weight-Loss Drug Advertising
- United StatesLitigation2026-07-20MassLive.comDrug company to pay $4.7M after admitting it paid providers to use its product
- United StatesLitigation2026-07-19MassLive.comMass. drug company settles kickback scheme lawsuit for $4.7M
- United KingdomLitigation2026-07-08Chemist+DruggistTesco Pharmacy faces MHRA action over weight loss POM ad
- United KingdomLitigation2026-07-08Pharmacy BusinessTesco Pharmacy, 2 others amend advertisements after MHRA action
2025 2
- United StatesLitigation2025-05-09U.S. Department of JusticePharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product
- United StatesLitigation2025-05-09U.S. Department of JusticePharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product
2024 10
- United StatesLitigation2024-12-13U.S. Department of JusticeUnited States Settles False Claims Act Allegations Against Pharmaceutical Distributor for Paying Kickbacks Through Inventory Management Systems
- United StatesLitigation2024-11-15U.S. Department of JusticePharmaceutical Company QOL Medical and CEO Agree to Pay $47M for Allegedly Paying Kickbacks to Induce Claims for QOL’s Drug Sucraid
- United StatesLitigation2024-10-10U.S. Department of JusticeTeva Pharmaceuticals Agrees to Pay $425 Million to Resolve Kickback Allegations
- United StatesLitigation2024-10-10U.S. Department of JusticeDrug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing
- United StatesLitigation2024-10-10U.S. Department of JusticeDrug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing
- United StatesLitigation2024-09-04U.S. Department of JusticePharmaceutical Company Pays $25 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
- United StatesLitigation2024-09-04U.S. Department of JusticePharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
- United StatesLitigation2024-02-22U.S. Department of JusticeFourteen Indicted in Pharmaceutical Kickback Case
- United StatesLitigation2024-02-15U.S. Department of JusticeCalifornia Pharmaceutical Company to Pay $750,000 to Resolve False Claims Act Liability for Allegedly Paying Kickbacks to Induce Prescriptions of Opioid Products
- United StatesLitigation2024-02-15U.S. Department of JusticeCalifornia Pharmaceutical Company to Pay $750,000 to Resolve False Claims Act Liability for Allegedly Paying Kickbacks to Induce Prescriptions of Opioid Products
2023 2
- United StatesLitigation2023-12-21U.S. Department of JusticePharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for Its Drug Crysvita
- United StatesLitigation2023-12-21U.S. Department of JusticePharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for its Drug Crysvita
2022 3
- United StatesLitigation2022-11-01U.S. Department of JusticeHudson Physician and Ohio Pharmaceutical Rep Plead Guilty to Roles in Prescription Drug Kickback Conspiracy
- United StatesLitigation2022-10-03U.S. Department of JusticeFlorida Medical Practice Agrees to Pay $130,000 to Resolve Allegations That it Received Kickbacks from Pharmaceutical Distributor
- United StatesLitigation2022-07-18U.S. Department of JusticeCalifornia Pain Specialist Agrees to Settle Alleged Receipt of Kickbacks from Pharmaceutical Companies Purdue Pharma and Depomed
2021 1
- United StatesLitigation2021-05-04U.S. Department of JusticePharmaceutical Manufacturer Agrees to Pay $12.6 Million to Resolve Allegations it Provided Kickbacks Through Donations to a Third-Party Charity
2020 4
- United StatesLitigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process
- United StatesLitigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals to pay U.S. $20.75 million to settle False Claims Act allegations relating to promotion of unsupported drug administration process
- United StatesLitigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals to pay U.S. $20.75 million to settle False Claims Act allegations relating to promotion of unsupported drug administration process
- United StatesLitigation2020-07-10U.S. Department of JusticePhysician Assistant to Pay $25,000 to Resolve Allegations of Receiving Kickbacks from Pharmaceutical Company
2019 23
- United StatesLitigation2019-12-05U.S. Department of JusticeManhattan Doctor Convicted In Manhattan Federal Court Of Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- United StatesLitigation2019-11-20U.S. Department of JusticeThird Foundation Resolves Allegations that it Conspired with Pharmaceutical Companies to Pay Kickbacks to Medicare Patients
- United StatesLitigation2019-10-25U.S. Department of JusticeFoundations Resolve Allegations of Enabling Pharmaceutical Companies to Pay Kickbacks to Medicare Patients
- United StatesLitigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- United StatesLitigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- United StatesLitigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- United StatesLitigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- United StatesLitigation2019-09-11District Court, District of ColumbiaKennedy v. Novo A/S
- United StatesLitigation2019-08-16U.S. Department of JusticeFourth Manhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- United StatesLitigation2019-08-02U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- United StatesLitigation2019-06-26U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- United StatesLitigation2019-06-25U.S. Department of JusticeNew Jersey/Pennsylvania Doctor Indicted For Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Powerful Fentanyl Drug
- United StatesLitigation2019-05-31U.S. Department of JusticeHeritage Pharmaceuticals Pays Over $7 Million to Resolve Civil False Claims Act Allegations
- United StatesLitigation2019-05-31U.S. Department of JusticePharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations
- United StatesLitigation2019-05-29U.S. Department of JusticePharmaceutical Company to Pay $3.5M to Resolve Allegations of Paying Kickbacks to Doctors
- United StatesLitigation2019-04-30U.S. Department of JusticePharmaceutical Company Agrees to Pay $17.5 Million to Resolve Allegations of Kickbacks to Medicare Patients and Physicians
- United StatesLitigation2019-04-30U.S. Department of JusticePharmaceutical Company Agrees to Pay $17.5 Million to Resolve Allegations of Kickbacks to Medicare Patients and Physicians
- United StatesLitigation2019-04-25U.S. Department of JusticeTwo Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations That They Paid Kickbacks Through Copay Assistance Foundations
- United StatesLitigation2019-04-25U.S. Department of JusticeTwo Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations that they Paid Kickbacks Through Co-Pay Assistance Foundations
- United StatesLitigation2019-04-08District Court, District of ColumbiaKennedy v. Novo A/S
- United StatesLitigation2019-04-04U.S. Department of JusticeThree Pharmaceutical Companies Agree to Pay a Total of Over $122 Million to Resolve Allegations that they Paid Kickbacks Through Co-Pay Assistance Foundations
- United StatesLitigation2019-04-04U.S. Department of JusticeThree Pharmaceutical Companies Agree to Pay a Total of Over $122 Million to Resolve Allegations That They Paid Kickbacks Through Co-Pay Assistance Foundations
- United StatesLitigation2019-02-14U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
2018 3
- United StatesLitigation2018-12-06U.S. Department of JusticeActelion Pharmaceuticals Agrees to Pay $360 Million to Resolve Allegations that it Paid Kickbacks Through a Co-Pay Assistance Foundation
- United StatesLitigation2018-10-26U.S. Department of JusticeAbbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor®
- United StatesLitigation2018-03-16U.S. Department of JusticeFive Manhattan Doctors Indicted For Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Powerful Fentanyl Narcotic
2017 2
- United StatesLitigation2017-07-24U.S. Department of JusticeCelgene Agrees to Pay $280 Million to Resolve Fraud Allegations Related to Promotion of Cancer Drugs For Uses Not Approved by FDA
- United StatesLitigation2017-02-13U.S. Department of JusticeFormer CEO of Nebraska Pharmaceutical Benefits Manager Guilty in Kickback Scheme
2016 7
- United StatesLitigation2016-12-15U.S. Department of JusticeForest Laboratories and Forest Pharmaceuticals to Pay $38 million to Resolve Kickback Allegations Under the False Claims Act
- United StatesLitigation2016-12-15U.S. Department of JusticeForest Laboratories and Forest Pharmaceuticals to Pay $38 million to Resolve Kickback Allegations Under the False Claims Act
- United StatesLitigation2016-06-09U.S. Department of JusticeManhattan U.S. Attorney Announces $54 Million Settlement Against Salix Pharmaceuticals For Using “Speaker Programs” As Mechanism To Pay Illegal Kickbacks To Doctors To Induce Them To Prescribe Salix Products
- United StatesLitigation2016-06-09U.S. Department of JusticeFormer Pharmaceutical Company Employees Arrested For Participating In Fentanyl Kickback Scheme
- United StatesLitigation2016-06-06U.S. Department of JusticePharmaceutical Companies to Pay $67 Million To Resolve False Claims Act Allegations Relating to Tarceva
- United StatesLitigation2016-06-06U.S. Department of JusticePharmaceutical Companies To Pay $67 Million To Resolve False Claims Act Allegations Relating To Tarceva
- United StatesLitigation2016-04-01Nature Reviews Drug DiscoveryAmarin agreement opens off-label promotion door
2015 5
- United StatesLitigation2015-11-20U.S. Department of JusticeManhattan U.S. Attorney Announces $370 Million Civil Fraud Settlement Against Novartis Pharmaceuticals For Kickback Scheme Involving High-Priced Prescription Drugs, Along With $20 Million Forfeiture Of Proceeds From The Scheme
- United StatesLitigation2015-06-17U.S. Department of JusticeManhattan U.S. Attorney Settles Civil Fraud Claims Against Inspire Pharmaceuticals, Inc. For Its Misleading Marketing Designed To Cause Prescriptions Of Azasite For Non-Fda Approved Uses
- United StatesLitigation2015-02-13U.S. Department of JusticeIllinois Physician Pleads Guilty to Taking Kickbacks from Pharmaceutical Company and Agrees to Pay $3.79 Million to Settle Civil False Claims Act Case
- United StatesLitigation2015-02-13U.S. Department of JusticeIllinois Physician Pleads Guilty to Taking Kickbacks from Pharmaceutical Company and Agrees to Pay $3.79 Million to Settle Civil False Claims Act Case
- United StatesLitigation2015-01-09U.S. Department of JusticePharmaceutical Manufacturer Daiichi-Sankyo to Pay $39 Million to Resolve Allegations that It Paid Kickbacks to Physicians
2014 9
- United StatesLitigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- United StatesLitigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC To Pay $56.5 Million To Resolve False Claims Act Allegations Relating To Marketing, Promotion
- United StatesLitigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- United StatesLitigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC To Pay $56.5 Million To Resolve False Claims Act Allegations Relating To Marketing, Promotion
- United StatesLitigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- United StatesLitigation2014-03-26District Court, D. MassachusettsUnited States v. Pfizer, Inc.
- United StatesLitigation2014-02-21U.S. Department of JusticeEndo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses
- United StatesLitigation2014-02-21U.S. Department of JusticeEndo Pharmaceuticals And Endo Health Solutions To Pay $192.7 Million To Resolve Criminal And Civil Liability Relating To Marketing Of Prescription Drug Lidoderm For Unapproved Uses
- JapanLitigation2014-01-16BMJNovartis faces charges in Japan over promotion of valsartan to doctors
2013 7
- United StatesLitigation2013-11-01Texas law reviewOff-Label Drug Promotion and the Use of Disclaimers*
- United StatesLitigation2013-07-30U.S. Department of JusticeWyeth Pharmaceuticals Agrees to Pay $490.9 Million for Marketing the Prescription Drug Rapamune for Unapproved Uses
- United StatesLitigation2013-07-30U.S. Department of JusticeWyeth Pharmaceuticals Agrees To Pay $490.9 Million For Marketing The Prescription Drug Rapamune For Unapproved Uses
- United StatesLitigation2013-07-18U.S. Department of JusticePharmaceutical Company Agrees To Pay $3.5 Million To Settle False Claims Act Allegations
- United StatesLitigation2013-05-24U.S. Department of JusticeISTA Pharmaceuticals, Inc. Plead Guilty to Federal Felony Charges; Will Pay $33.5 Million to Resolve Criminal lLability and False Claims Act Allegations
- United StatesLitigation2013-03-05U.S. Department of JusticePar Pharmaceuticals Pleads Guilty and Agrees to Pay $45 Million to Resolve Civil and Criminal Allegations Related to Off-Label Marketing
- United StatesLitigation2013-03-05U.S. Department of JusticePar Pharmaceuticals Pleads Guilty and Agrees to Pay $45 Million to Resolve Civil and Criminal Allegations Related to Off-Label Marketing
2012 5
- United StatesLitigation2012-12-27U.S. Department of JusticeVictory Pharma Inc. of San Diego Pays $11.4 Million to Resolve Kickback Allegations in Connection with Promotion of Its Drugs
- United StatesLitigation2012-12-12U.S. Department of JusticePfizer Agrees to Pay $55 Million for IllegallyPromoting Protonix for Off-Label Use
- United StatesLitigation2012-05-07U.S. Department of JusticeAbbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote
- United StatesLitigation2012-03-28U.S. Department of JusticeMississippi Pharmaceutical Firm and CEO to Pay $2.8 Million to Resolve Allegations of Illegal Marketing of Unapproved Drugs
- CanadaLitigation2012-02-21Canadian Medical Association JournalProhibition against off-label drug promotion challenged
2011 7
- United StatesLitigation2011-08-10District Court, D. New JerseyIn Re Neurontin Antitrust Litigation
- United StatesLitigation2011-06-09U.S. Department of JusticeU.S. Subsidiary of Belgian Pharmaceutical Manufacturer Pleads Guilty to Off-Label Promotion; Company to Pay More Than $34 Million
- United StatesLitigation2011-05-04U.S. Department of JusticePharmaceutical Giant, Serono, Agrees to Pay $44.3 Million to Settle False Claims Act Case
- United StatesLitigation2011-04-05PLoS MedicineStrategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
- United StatesLitigation2011-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations
- KoreaLitigation2011-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)Regulation of Pharmaceutical Industry Interactions with Health Care Professionals
- KoreaLitigation2011-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)Regulation of Pharmaceutical Industry Interactions with Health Care Professionals
2010 8
- United StatesLitigation2010-12-07U.S. Department of JusticeKos Pharmaceuticals to Pay More Than $41 Million to Resolve Kickback and Off-Label Promotion Allegations
- United StatesLitigation2010-12-07U.S. Department of JusticeKos Pharmaceuticals to Pay More Than $41 Million to Resolve Kickback and Off-Label Promotion Allegations
- United StatesLitigation2010-09-30U.S. Department of JusticeNovartis Pharmaceuticals Corp. to Pay More Than $420 Million to Resolve Off-label Promotion and Kickback Allegations
- United StatesLitigation2010-09-01U.S. Department of JusticeAllergan Agrees to Plead Guilty and Pay $600 Million to Resolve Allegations of Off-Label Promotion of Botox®
- United StatesLitigation2010-04-29U.S. Department of JusticeTwo Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
- United StatesLitigation2010-04-27U.S. Department of JusticePharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing
- United StatesLitigation2010-04-27U.S. Department of JusticePharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing
- United StatesLitigation2010-03-16U.S. Department of JusticeAlpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection with Promotion of Drug Kadian
2009 3
- United StatesLitigation2009-11-09Psychology todayDrug Makers Still Repeatedly Breaking the Law over 'Off-Label' Promotion
- United StatesLitigation2009-05-13District Court, D. MassachusettsIn re Neurontin Marketing, Sales Practices & Products Liability Litigation
- United StatesLitigation2009-01-15U.S. Department of JusticeEli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa
2008 1
- United StatesLitigation2008-05-29BMJMerck to pay $58m in settlement over rofecoxib advertising
2004 1
- United StatesLitigation2004-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)A Case at a Crossroad: United States ex rel. Franklin v. Parke-Davis and the Intersection of Regulating Promotion of Off-Label Uses and Medicaid Fraud and Abuse